332 related articles for article (PubMed ID: 12421928)
1. Lack of effector cell function and altered tetramer binding of tumor-infiltrating lymphocytes.
Blohm U; Roth E; Brommer K; Dumrese T; Rosenthal FM; Pircher H
J Immunol; 2002 Nov; 169(10):5522-30. PubMed ID: 12421928
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
[TBL] [Abstract][Full Text] [Related]
3. Crucial role of TNF-alpha in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo.
Prévost-Blondel A; Roth E; Rosenthal FM; Pircher H
J Immunol; 2000 Apr; 164(7):3645-51. PubMed ID: 10725721
[TBL] [Abstract][Full Text] [Related]
4. Conversion of tyrosine to the inflammation-associated analog 3'-nitrotyrosine at either TCR- or MHC-contact positions can profoundly affect recognition of the MHC class I-restricted epitope of lymphocytic choriomeningitis virus glycoprotein 33 by CD8 T cells.
Hardy LL; Wick DA; Webb JR
J Immunol; 2008 May; 180(9):5956-62. PubMed ID: 18424715
[TBL] [Abstract][Full Text] [Related]
5. Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus.
Basler M; Youhnovski N; Van Den Broek M; Przybylski M; Groettrup M
J Immunol; 2004 Sep; 173(6):3925-34. PubMed ID: 15356141
[TBL] [Abstract][Full Text] [Related]
6. Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison.
Storni T; Bachmann MF
J Immunol; 2004 May; 172(10):6129-35. PubMed ID: 15128799
[TBL] [Abstract][Full Text] [Related]
7. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
8. Effects of an epitope-specific CD8+ T-cell response on murine coronavirus central nervous system disease: protection from virus replication and antigen spread and selection of epitope escape mutants.
Chua MM; MacNamara KC; San Mateo L; Shen H; Weiss SR
J Virol; 2004 Feb; 78(3):1150-9. PubMed ID: 14722270
[TBL] [Abstract][Full Text] [Related]
9. Virus-induced activation of self-specific TCR alpha beta CD8 alpha alpha intraepithelial lymphocytes does not abolish their self-tolerance in the intestine.
Saurer L; Seibold I; Rihs S; Vallan C; Dumrese T; Mueller C
J Immunol; 2004 Apr; 172(7):4176-83. PubMed ID: 15034030
[TBL] [Abstract][Full Text] [Related]
10. CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity.
Hermans IF; Ritchie DS; Yang J; Roberts JM; Ronchese F
J Immunol; 2000 Mar; 164(6):3095-101. PubMed ID: 10706699
[TBL] [Abstract][Full Text] [Related]
11. Differential presentation of the same MHC class I epitopes by fibroblasts and dendritic cells.
Butz EA; Bevan MJ
J Immunol; 1998 Mar; 160(5):2139-44. PubMed ID: 9498751
[TBL] [Abstract][Full Text] [Related]
12. Transient loss of MHC class I tetramer binding after CD8+ T cell activation reflects altered T cell effector function.
Drake DR; Ream RM; Lawrence CW; Braciale TJ
J Immunol; 2005 Aug; 175(3):1507-15. PubMed ID: 16034088
[TBL] [Abstract][Full Text] [Related]
13. High Frequencies of Anti-Host Reactive CD8+ T Cells Ignore Non-Hematopoietic Antigen after Bone Marrow Transplantation in a Murine Model.
Gassa A; Kalkavan H; Jian F; Duhan V; Khairnar V; Shaabani N; Honke N; Carpinteiro A; Botezatu L; Crivello P; Dolff S; Ferencik S; Häussinger D; Khandanpour C; Fleischhauer K; Witzke O; Wahlers T; Hardt C; Lang PA; Lang KS
Cell Physiol Biochem; 2016; 38(4):1343-53. PubMed ID: 27007114
[TBL] [Abstract][Full Text] [Related]
14. Protective immunity from naive CD8+ T cells activated in vitro with MHC class I binding immunogenic peptides and IL-2 in the absence of specialized APCs.
Hauser C; Zipprich F; Leblond I; Wirth S; Hügin AW
J Immunol; 1999 Jul; 163(1):330-6. PubMed ID: 10384132
[TBL] [Abstract][Full Text] [Related]
15. IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2.
Jackaman C; Bundell CS; Kinnear BF; Smith AM; Filion P; van Hagen D; Robinson BW; Nelson DJ
J Immunol; 2003 Nov; 171(10):5051-63. PubMed ID: 14607902
[TBL] [Abstract][Full Text] [Related]
16. IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections.
Bahl K; Kim SK; Calcagno C; Ghersi D; Puzone R; Celada F; Selin LK; Welsh RM
J Immunol; 2006 Apr; 176(7):4284-95. PubMed ID: 16547266
[TBL] [Abstract][Full Text] [Related]
17. CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses.
Vabulas RM; Pircher H; Lipford GB; Häcker H; Wagner H
J Immunol; 2000 Mar; 164(5):2372-8. PubMed ID: 10679072
[TBL] [Abstract][Full Text] [Related]
18. Peptidic termini play a significant role in TCR recognition.
Wang B; Sharma A; Maile R; Saad M; Collins EJ; Frelinger JA
J Immunol; 2002 Sep; 169(6):3137-45. PubMed ID: 12218131
[TBL] [Abstract][Full Text] [Related]
19. Induction of insert-specific immune response in mice by hamster polyomavirus VP1 derived virus-like particles carrying LCMV GP33 CTL epitope.
Mazeike E; Gedvilaite A; Blohm U
Virus Res; 2012 Jan; 163(1):2-10. PubMed ID: 21864590
[TBL] [Abstract][Full Text] [Related]
20. Innate immunity together with duration of antigen persistence regulate effector T cell induction.
Storni T; Ruedl C; Renner WA; Bachmann MF
J Immunol; 2003 Jul; 171(2):795-801. PubMed ID: 12847247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
